Piper Sandler Lowers Intuitive Surgical (NASDAQ:ISRG) Price Target to $580.00

Intuitive Surgical (NASDAQ:ISRG) had its price target reduced by research analysts at Piper Sandler from $620.00 to $580.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical equipment provider’s stock. Piper Sandler’s price target indicates a potential upside of 21.13% from the company’s previous close.

Several other research analysts also recently commented on ISRG. Mizuho set a $525.00 price target on shares of Intuitive Surgical and gave the company a “neutral” rating in a report on Monday, April 13th. Barclays set a $712.00 price target on shares of Intuitive Surgical and gave the company an “overweight” rating in a report on Monday, January 26th. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target for the company in a report on Wednesday, March 11th. Finally, BTIG Research reissued a “buy” rating and issued a $574.00 price target on shares of Intuitive Surgical in a report on Wednesday. Eighteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $581.91.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $478.82 on Wednesday. The company has a market cap of $170.04 billion, a P/E ratio of 58.04, a P/E/G ratio of 3.78 and a beta of 1.68. The stock’s fifty day moving average price is $477.54 and its two-hundred day moving average price is $515.16. Intuitive Surgical has a 1 year low of $427.84 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter in the prior year, the business posted $1.81 earnings per share. The business’s quarterly revenue was up 23.0% on a year-over-year basis. On average, analysts expect that Intuitive Surgical will post 8.16 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Gary S. Guthart sold 24,500 shares of the stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the transaction, the director directly owned 3,694 shares in the company, valued at $1,958,189.40. This trade represents a 86.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Mark Brosius sold 2,362 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total value of $1,177,882.16. Following the completion of the transaction, the senior vice president directly owned 3,554 shares in the company, valued at $1,772,308.72. This trade represents a 39.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 32,943 shares of company stock valued at $17,279,568. 0.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of large investors have recently bought and sold shares of the stock. First Pacific Financial increased its stake in Intuitive Surgical by 105.6% in the 1st quarter. First Pacific Financial now owns 111 shares of the medical equipment provider’s stock worth $51,000 after purchasing an additional 57 shares during the period. MQS Management LLC purchased a new position in Intuitive Surgical in the 1st quarter worth approximately $513,000. Eagle Wealth Advisors LLC increased its stake in Intuitive Surgical by 15.7% in the 1st quarter. Eagle Wealth Advisors LLC now owns 1,237 shares of the medical equipment provider’s stock worth $570,000 after purchasing an additional 168 shares during the period. Premier Path Wealth Partners LLC increased its stake in Intuitive Surgical by 7.8% in the 1st quarter. Premier Path Wealth Partners LLC now owns 3,119 shares of the medical equipment provider’s stock worth $1,438,000 after purchasing an additional 225 shares during the period. Finally, Mayflower Financial Advisors LLC increased its stake in Intuitive Surgical by 5.8% in the 1st quarter. Mayflower Financial Advisors LLC now owns 491 shares of the medical equipment provider’s stock worth $226,000 after purchasing an additional 27 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat and raised outlook — ISRG reported stronger‑than‑expected Q1 revenue and EPS, raised full‑year procedure guidance and cited broad procedure adoption; that drove the initial rally after the print. Read More.
• Positive Sentiment: da Vinci 5 and innovation-led revenue — Analysts and coverage note revenues are outpacing procedures as da Vinci 5 placements and service/consumable pricing power shift growth toward innovation and value-based revenue. Read More.
• Positive Sentiment: Analysts reaffirm bullish views — several firms reiterated buy/overweight ratings and raised forecasts after the quarter, saying procedure momentum and platform adoption support longer‑term upside. Read More.
• Neutral Sentiment: Market commentary highlights long‑term case — investment pieces argue ISRG remains a secular winner in robotic surgery despite near‑term volatility; these are thematic views rather than short‑term catalysts. Read More.
• Negative Sentiment: Mixed/trimmed price targets — several banks trimmed price targets post‑earnings (some materially) even while keeping buy/overweight ratings; the patchwork of cuts likely contributed to selling pressure. Read More.
• Negative Sentiment: Cybersecurity note — the company disclosed a contained cyber incident and is remediating; while management calls it contained, such disclosures can increase near‑term uncertainty for investors. Read More.
• Negative Sentiment: Guidance conservatism / profit‑taking — some coverage points out the company raised guidance modestly relative to the beat, which may signal conservative assumptions and prompted traders to book gains after the initial surge. Read More.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.